Anixa Biosciences (ANIX) Amortization of Deferred Charges (2021 - 2025)

Anixa Biosciences (ANIX) has 5 years of Amortization of Deferred Charges data on file, last reported at $9000.0 in Q4 2025.

• Quarterly Amortization of Deferred Charges changed 0.0% year-over-year to $9000.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $36000.0 (down 2.7% YoY) and the FY2025 annual result came in at $36000.0, down 2.7% from the prior year.
• Amortization of Deferred Charges steadied at $9000.0 in Q4 2025, from $9000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $16000.0 in Q4 2021 to a low of $3000.0 in Q3 2024.
• A 5-year average of $11050.0 and a median of $11000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
• Annual changes were most pronounced in 2024 — Amortization of Deferred Charges sank 72.73% — and 2025, when it surged 200.0%.
• Tracing ANIX's Amortization of Deferred Charges over 5 years: stood at $16000.0 in 2021, then plunged by 31.25% to $11000.0 in 2022, then increased by 9.09% to $12000.0 in 2023, then retreated by 25.0% to $9000.0 in 2024, then changed by 0.0% to $9000.0 in 2025.
• The last three Amortization of Deferred Charges figures came in at $9000.0 (Q4 2025), $9000.0 (Q3 2025), and $9000.0 (Q2 2025), per Business Quant data.